Edward Carr Insider Trades & Stock Holdings

CHIEF ACCOUNTING OFFICER · Dianthus Therapeutics, Inc. · Latest filing Sep 17, 2026

Edward Carr, CHIEF ACCOUNTING OFFICER at Dianthus Therapeutics, Inc. has 1 Form 4 trade on file since Sep 17, 2026. Open-market activity: 0 purchases ($0) and 1 sale ($2.03M), net -$2.03M. Latest filing: disposed of 20K shares of $DNTH on Sep 17, 2026 at $101.38.

Trades on file

1

Open-market bought

$0

Open-market sold

$2.03M

Net open-market

-$2.03M

Latest filing

Sep 17, 2026

All insider trades by Edward Carr

Date	Ticker	Type	Shares	Price	Value	Owned after	ΔOwn	1W	1M	6M	Role	Filing	Story
Sep 17, 2026	$DNTH	Sell (Open-market sale) 10b5-1	20K	$101.38	$2.03M			-10.3%			CHIEF ACCOUNTING OFFICER		—

"Buy" means shares acquired on the Form 4 (including grants and option exercises); "Sell" means shares disposed. 1W / 1M / 6M = how the stock moved after the trade.

Stocks Edward Carr traded

• $DNTH

Frequently asked questions

Has Edward Carr been buying or selling stock?

Edward Carr has 0 open-market purchases and 1 open-market sale on file, net -$2.03M. Grants, option exercises and tax withholding are listed separately because they are not open-market trades.

What was Edward Carr's latest insider trade?

disposed of 20K shares of $DNTH on Sep 17, 2026 at $101.38.

Data comes from public SEC Form 4 and 13F filings and STOCK Act disclosures. Dates are the trade or filing date reported. This page is for research only and is not investment advice.